Acute damage of gastroduodenal mucosa by acetylsalicylic acid: no prolonged protection by antacids

Aliment Pharmacol Ther. 1989 Dec;3(6):585-90. doi: 10.1111/j.1365-2036.1989.tb00251.x.

Abstract

Twenty healthy volunteers participated in a double-blind, crossover study to evaluate endoscopically whether low-dose antacids have any prolonged and pH-independent protective capacity against gastroduodenal mucosal damage induced by acetylsalicylic acid. Antacid or placebo one tablet q.d.s. was given for 1.5 days. Acetylsalicylic acid (1.5 g) was administered 3 h after the last dose of antacid/placebo, and gastroscopy was performed 1 h thereafter. Thirteen of 20 subjects showed a decrease in total damage with antacids as compared with placebo, but the difference did not reach statistical significance. Thus, protection by antacids against acetylsalicylic acid-induced gastric mucosal lesions could not be documented at a time when intragastric pH presumably had returned to normal.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antacids / pharmacology*
  • Aspirin / adverse effects*
  • Aspirin / antagonists & inhibitors
  • Double-Blind Method
  • Duodenum / drug effects
  • Endoscopy, Gastrointestinal
  • Female
  • Gastric Mucosa / drug effects*
  • Humans
  • Hydrogen-Ion Concentration
  • Intestinal Mucosa / drug effects*
  • Male
  • Middle Aged

Substances

  • Antacids
  • Aspirin